APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mebendazole

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

Selected research

Market Outlook & Growth Opportunities

Global Mebendazole Market Outlook and Growth Opportunities 2026

28 December 2025197 pages

Choose your research edition.

Industry ResearchMebendazole Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Mebendazole Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Mebendazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mebendazole Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mebendazole Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.

Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.

Read the full market overview

Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.

This report provides an overview of the global Mebendazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mebendazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mebendazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mebendazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Mebendazole Segment by Company

Johnson & Johnson

Amneal Pharmaceuticals

Cadila Pharmaceuticals

Eipico

Esteve Pharmaceuticals

Tenry

Mebendazole Segment by Type

Tablet

Oral Suspension

Mebendazole Segment by Application

Below 2 Years Old

Above 2 Years Old

Mebendazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mebendazole status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mebendazole market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mebendazole significant trends, drivers, influence factors in global and regions.

6. To analyze Mebendazole competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mebendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mebendazole market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mebendazole industry.

Chapter 3: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mebendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mebendazole in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mebendazole Industry Trends Table 2. Mebendazole Industry Drivers Table 3. Mebendazole Industry Opportunities and Challenges Table 4. Mebendazole Industry Restraints Table 5. Global Mebendazole Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mebendazole Revenue Share by Company (2021-2026) Table 7. Global Mebendazole Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Mebendazole Sales Volume Share by Company (2021-2026) Table 9. Global Mebendazole Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Mebendazole Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mebendazole Key Company Manufacturing Base & Headquarters Table 12. Global Mebendazole Company, Product Type & Application Table 13. Global Mebendazole Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mebendazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Oral Suspension Table 19. Global Mebendazole Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Mebendazole Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Mebendazole Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Mebendazole Sales Volume Share by Type (2021-2026) Table 23. Global Mebendazole Sales Volume Share by Type (2027-2032) Table 24. Global Mebendazole Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mebendazole Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Mebendazole Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Mebendazole Sales Value Share by Type (2021-2026) Table 28. Global Mebendazole Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Below 2 Years Old Table 30. Significant Companies of Above 2 Years Old Table 31. Global Mebendazole Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Mebendazole Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Mebendazole Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Mebendazole Sales Volume Share by Application (2021-2026) Table 35. Global Mebendazole Sales Volume Share by Application (2027-2032) Table 36. Global Mebendazole Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Mebendazole Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Mebendazole Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Mebendazole Sales Value Share by Application (2021-2026) Table 40. Global Mebendazole Sales Value Share by Application (2027-2032) Table 41. Global Mebendazole Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Mebendazole Sales by Region (2021-2026) & (K Units) Table 43. Global Mebendazole Sales Market Share by Region (2021-2026) Table 44. Global Mebendazole Sales by Region (2027-2032) & (K Units) Table 45. Global Mebendazole Sales Market Share by Region (2027-2032) Table 46. Global Mebendazole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Mebendazole Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Mebendazole Sales Value Share by Region (2021-2026) Table 49. Global Mebendazole Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Mebendazole Sales Value Share by Region (2027-2032) Table 51. Global Mebendazole Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Mebendazole Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Mebendazole Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Mebendazole Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Mebendazole Sales by Country (2021-2026) & (K Units) Table 56. Global Mebendazole Sales Market Share by Country (2021-2026) Table 57. Global Mebendazole Sales by Country (2027-2032) & (K Units) Table 58. Global Mebendazole Sales Market Share by Country (2027-2032) Table 59. Global Mebendazole Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Mebendazole Sales Value Market Share by Country (2021-2026) Table 61. Global Mebendazole Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Mebendazole Sales Value Market Share by Country (2027-2032) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Mebendazole Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Mebendazole Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Amneal Pharmaceuticals Company Information Table 69. Amneal Pharmaceuticals Business Overview Table 70. Amneal Pharmaceuticals Mebendazole Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Amneal Pharmaceuticals Mebendazole Product Portfolio Table 72. Amneal Pharmaceuticals Recent Development Table 73. Cadila Pharmaceuticals Company Information Table 74. Cadila Pharmaceuticals Business Overview Table 75. Cadila Pharmaceuticals Mebendazole Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Cadila Pharmaceuticals Mebendazole Product Portfolio Table 77. Cadila Pharmaceuticals Recent Development Table 78. Eipico Company Information Table 79. Eipico Business Overview Table 80. Eipico Mebendazole Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Eipico Mebendazole Product Portfolio Table 82. Eipico Recent Development Table 83. Esteve Pharmaceuticals Company Information Table 84. Esteve Pharmaceuticals Business Overview Table 85. Esteve Pharmaceuticals Mebendazole Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Esteve Pharmaceuticals Mebendazole Product Portfolio Table 87. Esteve Pharmaceuticals Recent Development Table 88. Tenry Company Information Table 89. Tenry Business Overview Table 90. Tenry Mebendazole Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Tenry Mebendazole Product Portfolio Table 92. Tenry Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Mebendazole Distributors List Table 96. Mebendazole Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Mebendazole Product Image Figure 2. Global Mebendazole Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mebendazole Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mebendazole Sales (2021-2032) & (K Units) Figure 5. Global Mebendazole Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Mebendazole Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Oral Suspension Image Figure 11. Global Mebendazole Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Mebendazole Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Mebendazole Sales Volume Share by Type (2021-2032) Figure 14. Global Mebendazole Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Mebendazole Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Mebendazole Sales Value Share by Type (2021-2032) Figure 17. Below 2 Years Old Image Figure 18. Above 2 Years Old Image Figure 19. Global Mebendazole Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Mebendazole Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Mebendazole Sales Volume Share by Application (2021-2032) Figure 22. Global Mebendazole Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Mebendazole Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Mebendazole Sales Value Share by Application (2021-2032) Figure 25. Global Mebendazole Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Mebendazole Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Mebendazole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Mebendazole Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Mebendazole Sales Value (2021-2032) & (US$ Million) Figure 30. North America Mebendazole Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Mebendazole Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Mebendazole Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Mebendazole Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Mebendazole Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Mebendazole Sales Value (2021-2032) & (US$ Million) Figure 36. South America Mebendazole Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Mebendazole Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Mebendazole Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Mebendazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Mebendazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Mebendazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Mebendazole Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Mebendazole Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Suspension
Applications
  • Below 2 Years Old
  • Above 2 Years Old
Companies covered
  • Johnson & Johnson
  • Amneal Pharmaceuticals
  • Cadila Pharmaceuticals
  • Eipico
  • Esteve Pharmaceuticals
  • Tenry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mebendazole Sales Value (2021-2032)
  4. 1.2.2 Global Mebendazole Sales Volume (2021-2032)
  5. 1.2.3 Global Mebendazole Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mebendazole Market Dynamics
  1. 2.1 Mebendazole Industry Trends
  2. 2.2 Mebendazole Industry Drivers
  3. 2.3 Mebendazole Industry Opportunities and Challenges
  4. 2.4 Mebendazole Industry Restraints
3 Mebendazole Market by Company
  1. 3.1 Global Mebendazole Company Revenue Ranking in 2025
  2. 3.2 Global Mebendazole Revenue by Company (2021-2026)
  3. 3.3 Global Mebendazole Sales Volume by Company (2021-2026)
  4. 3.4 Global Mebendazole Average Price by Company (2021-2026)
  5. 3.5 Global Mebendazole Company Ranking (2024-2026)
  6. 3.6 Global Mebendazole Company Manufacturing Base and Headquarters
  7. 3.7 Global Mebendazole Company Product Type and Application
  8. 3.8 Global Mebendazole Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mebendazole Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mebendazole Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mebendazole Market by Type
  1. 4.1 Mebendazole Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Suspension
  4. 4.2 Global Mebendazole Sales Volume by Type
  5. 4.2.1 Global Mebendazole Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mebendazole Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Mebendazole Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Mebendazole Sales Value by Type
  9. 4.3.1 Global Mebendazole Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mebendazole Sales Value by Type (2021-2032)
  11. 4.3.3 Global Mebendazole Sales Value Share by Type (2021-2032)
5 Mebendazole Market by Application
  1. 5.1 Mebendazole Application Introduction
  2. 5.1.1 Below 2 Years Old
  3. 5.1.2 Above 2 Years Old
  4. 5.2 Global Mebendazole Sales Volume by Application
  5. 5.2.1 Global Mebendazole Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mebendazole Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Mebendazole Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Mebendazole Sales Value by Application
  9. 5.3.1 Global Mebendazole Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mebendazole Sales Value by Application (2021-2032)
  11. 5.3.3 Global Mebendazole Sales Value Share by Application (2021-2032)
6 Mebendazole Regional Sales and Value Analysis
  1. 6.1 Global Mebendazole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mebendazole Sales by Region (2021-2032)
  3. 6.2.1 Global Mebendazole Sales by Region: 2021-2026
  4. 6.2.2 Global Mebendazole Sales by Region (2027-2032)
  5. 6.3 Global Mebendazole Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mebendazole Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mebendazole Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mebendazole Sales Value by Region (2027-2032)
  9. 6.5 Global Mebendazole Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mebendazole Sales Value (2021-2032)
  12. 6.6.2 North America Mebendazole Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mebendazole Sales Value (2021-2032)
  15. 6.7.2 Europe Mebendazole Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mebendazole Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mebendazole Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mebendazole Sales Value (2021-2032)
  21. 6.9.2 South America Mebendazole Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mebendazole Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mebendazole Sales Value Share by Country, 2025 VS 2032
7 Mebendazole Country-level Sales and Value Analysis
  1. 7.1 Global Mebendazole Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mebendazole Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mebendazole Sales by Country (2021-2032)
  4. 7.3.1 Global Mebendazole Sales by Country (2021-2026)
  5. 7.3.2 Global Mebendazole Sales by Country (2027-2032)
  6. 7.4 Global Mebendazole Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mebendazole Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mebendazole Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mebendazole Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mebendazole Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mebendazole Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mebendazole Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mebendazole Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mebendazole Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mebendazole Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mebendazole Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mebendazole Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mebendazole Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mebendazole Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mebendazole Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mebendazole Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mebendazole Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mebendazole Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mebendazole Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mebendazole Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mebendazole Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mebendazole Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mebendazole Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mebendazole Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mebendazole Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mebendazole Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mebendazole Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mebendazole Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mebendazole Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mebendazole Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mebendazole Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mebendazole Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mebendazole Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mebendazole Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mebendazole Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mebendazole Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mebendazole Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mebendazole Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mebendazole Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mebendazole Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mebendazole Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mebendazole Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mebendazole Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mebendazole Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mebendazole Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mebendazole Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mebendazole Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mebendazole Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mebendazole Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mebendazole Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mebendazole Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mebendazole Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mebendazole Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mebendazole Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mebendazole Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mebendazole Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mebendazole Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mebendazole Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mebendazole Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mebendazole Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mebendazole Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mebendazole Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mebendazole Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mebendazole Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mebendazole Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mebendazole Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mebendazole Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mebendazole Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mebendazole Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mebendazole Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mebendazole Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mebendazole Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mebendazole Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mebendazole Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mebendazole Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mebendazole Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mebendazole Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mebendazole Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mebendazole Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mebendazole Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mebendazole Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mebendazole Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mebendazole Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mebendazole Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mebendazole Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mebendazole Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mebendazole Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Mebendazole Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Mebendazole Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Mebendazole Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Mebendazole Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Cadila Pharmaceuticals
  14. 8.3.1 Cadila Pharmaceuticals Company Information
  15. 8.3.2 Cadila Pharmaceuticals Business Overview
  16. 8.3.3 Cadila Pharmaceuticals Mebendazole Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cadila Pharmaceuticals Mebendazole Product Portfolio
  18. 8.3.5 Cadila Pharmaceuticals Recent Developments
  19. 8.4 Eipico
  20. 8.4.1 Eipico Company Information
  21. 8.4.2 Eipico Business Overview
  22. 8.4.3 Eipico Mebendazole Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eipico Mebendazole Product Portfolio
  24. 8.4.5 Eipico Recent Developments
  25. 8.5 Esteve Pharmaceuticals
  26. 8.5.1 Esteve Pharmaceuticals Company Information
  27. 8.5.2 Esteve Pharmaceuticals Business Overview
  28. 8.5.3 Esteve Pharmaceuticals Mebendazole Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Esteve Pharmaceuticals Mebendazole Product Portfolio
  30. 8.5.5 Esteve Pharmaceuticals Recent Developments
  31. 8.6 Tenry
  32. 8.6.1 Tenry Company Information
  33. 8.6.2 Tenry Business Overview
  34. 8.6.3 Tenry Mebendazole Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tenry Mebendazole Product Portfolio
  36. 8.6.5 Tenry Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mebendazole Value Chain Analysis
  2. 9.1.1 Mebendazole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mebendazole Sales Mode & Process
  6. 9.2 Mebendazole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mebendazole Distributors
  9. 9.2.3 Mebendazole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst